🔥 Trending Cetirizine Recall: What You Need to Know About the Antihistamine Contamination

A nationwide recall has been issued for specific lots of Cetirizine Hydrochloride Tablets USP 5 mg due to potential cross-contamination with ranitidine ¹². This recall was initiated voluntarily by Unique Pharmaceutical Laboratories, a division of J. B. Chemicals & Pharmaceuticals Ltd. ¹⁴.

What is Being Recalled?

The recall specifically targets four lots of Cetirizine Hydrochloride Tablets USP 5 mg ³⁵. These tablets are typically sold in 100-count bottles ⁹. Consumers can identify the recalled product by checking the name, manufacturer details, and lot number on the bottle ⁹.

Why is the Recall Happening?

The primary reason for the recall is the potential for cross-contamination with ranitidine ²³⁴. Ranitidine is a drug historically used to treat heartburn and severe acid reflux ⁴. The concern stems from the possibility that the cetirizine tablets may contain ranitidine ⁵.

Potential Risks of Contamination

The presence of ranitidine in cetirizine tablets poses a health risk, particularly for individuals who may be sensitive to ranitidine ⁷⁸. This cross-contamination could lead to severe hypersensitivity reactions and even anaphylaxis in some cases ⁷¹⁰. Anaphylaxis is a life-threatening allergic reaction that requires immediate medical attention.

Manufacturer and Regulatory Action

Unique Pharmaceutical Laboratories is conducting this recall voluntarily ¹⁴. The U.S. Food and Drug Administration (FDA) has been involved in announcing and overseeing this nationwide recall ¹⁴⁵. The recall aims to remove potentially contaminated products from the market to protect public health.